on 27 Nov 2018
Last Applicant/ Owned by
Northern Ireland Science Park
GB
Serial Number
79213643 filed on 08th Mar 2017
Registration Number
5614010 registered on 27th Nov 2018
Correspondent Address
Helen Hill Minsker
Filing Basis
1. filing basis filed as 66 a
Disclaimer
NO DATA
Chemical preparations for use in industry; chemical preparations for scientific purposes; biochemical substances and biochemical preparations for use in industry, science and research, namely, excipients for use in the manufacture of pharmaceutical preparations, cosmetic preparations, nutraceutical preparations, veterinary preparations, dietary supplements, foods and beverages and pharmaceutical pRead More
Chemicals and chemical preparations, namely, antiviral pharmaceutical preparations, anti-infective pharmaceutical preparations, anti-inflammatory pharmaceutical preparations, antiseptic pharmaceutical preparations, antibacterial pharmaceutical preparations, antibiotic pharmaceutical preparations; antifungal pharmaceutical preparations, anti-fibrotic pharmaceutical preparations; chemicals and chemical preparations, namely, pharmaceutical preparation for skin care; chemicals and chemical preparations, namely, pharmaceutical preparations for the treatment and prevention of cardiovascular diseases and disorders, musculoskeletal diseases and disorders, inflammatory diseases and disorders, respiratory and pulmonary diseases and disorders, immune system related diseases and disorders, hematological diseases and disorders, oncological diseases and disorders, urological diseases and disorders, gastro-intestinal diseases, eye diseases and conditions, heart rhythm disorders, kidney and nephropathic diseases, hematological disorders, diabetes, hypertension, skin disorders, damaged skin and tissue, [ winkles ] * wrinkles *, wounds and allergies, insect bites, dermatological diseases and disorders, HIV, cancer and tumors, bone diseases, arthritis, cardiopulmonary, infectious diseases, blood disorders, pain, sepsis, alopecia, obesity, cognitive disorders diseases, neurological disorders, hormonal disorders, disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceutical, nutraceutical and veterinary products; drug delivery agents consisting of nanoparticle compounds that facilitate delivery of a wide range of pharmaceutical, nutraceutical and veterinary products; drug delivery agents consisting of silicon compounds that facilitate delivery of a wide range of pharmaceutical, nutraceutical and veterinary products; drug delivery agents consisting of porous silicon compounds that facilitate delivery of a wide range of pharmaceutical, nutraceutical and veterinary products; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals skin care preparations; drug delivery agents in the form of powders, liquids and gels that provide controlled release of the active ingredients for a wide variety of pharmaceutical, nutraceutical and veterinary products
Chemical preparations for use in industry; chemical preparations for scientific purposes; biochemical substances and biochemical preparations for use in industry, science and research, namely, excipients for use in the manufacture of pharmaceutical preparations, cosmetic preparations, nutraceutical preparations, veterinary preparations, dietary supplements, foods and beverages and pharmaceutical preparations for topical use; reagents and substrates, namely, chemical compounds for use in patterning at nano scale or near nano scale; silicon for use in industry, science and research; pure non-metallic silicon sold in nanoparticle form for use in industry, science and research; pure non-metallic porous silicon sold in nanoparticle form for use in industry, science and research; silicon for use in stabilising of enzymes of chemical, biochemical and biological substances for use in industry and for scientific research purposes
No 79213643
No Service/Collective Mark
No 008814.00005
No
No
No
No
Yes
Yes
No
No
| Status Date | Action Taken |
|---|---|
| 27th Nov 2023 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED |
| 30th Jan 2020 | INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE |
| 06th Jan 2020 | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED |
| 25th Apr 2019 | CORRECTION UNDER SECTION 7 ¿ PROCESSED |
| 24th Apr 2019 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| 04th Apr 2019 | TEAS SECTION 7 REQUEST RECEIVED |
| 29th Mar 2019 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| 07th Mar 2019 | FINAL DISPOSITION PROCESSED |
| 07th Mar 2019 | FINAL DISPOSITION NOTICE SENT TO IB |
| 28th Feb 2019 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
